Pharmas will need patient strategies to reap rewards
This article was originally published in Scrip
Executive Summary
Unsustainable healthcare costs and the emergence of disruptive innovations is forcing life science companies to embrace a fundamental overhaul of business models to make them more patient-centric and better able to drive behavioural changes in consumers. This is the main conclusion from The third place: health care everywhere, Ernst & Young's latest annual report on the global life sciences industry.